旋極信息(300324.SZ):君威科技將成控股股東、綿陽市國資委為實控人 股票復牌
格隆匯9月2日丨旋極信息(300324.SZ)公吿稱,綿陽科技城新區君威科技有限公司(簡稱“君威科技”)擬以現金方式認購公司定增的約3.93億股股票;同時陳江濤承諾自2022年9月1日無條件地放棄公司約7766.23萬股份的表決權。
上述事項實施之後,君威科技將持有公司18.55%的股份,陳江濤及其一致行動人持有表決權股份佔比為12.61%,公司控股股東將由陳江濤變為君威科技,實際控制人將由陳江濤變為綿陽市國資委。
此外,公司股票自9月2日開市起復牌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.